PLUS1
Les meilleurs offres pour accéder les cours en temps réel en illimité |
|
Expert
Abonnement Mensuel
Seulement
|
|
Trade Alert US
Abonnement Mensuel
Seulement
|
|
Real-time Level 1 for Canada + USA
Abonnement Mensuel
Seulement
|
|
Prix hors taxes
|
| Nom Action | Symbole Action | Marché | Type | ISIN | Description Action |
|---|---|---|---|---|---|
| Pfizer | PFE | NYSE | Action ordinaire |
| Variation Action | Variation Action% | Cours Dernier | Plus Haut | Plus Bas | Ouverture | Clôture Veille | Dernier échange  |
|
|---|---|---|---|---|---|---|---|---|
| -0,13 | -0,31% | 41,86 | 41,98 | 41,77 | 41,83 | 41,99 | 16:55:53 |
| Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
|---|---|---|---|---|---|
| 26 971 | 4 823 908 | US$ 41,88 | US$ 202 014 312 | 22 632 060 | 35,32 - 46,47 |
| Dernière Transaction | Type | Quantités échangée | Prix transaction | Devise |
|---|---|---|---|---|
| 16:55:57 | 100 | US$ 41,86 | USD |
Bilan Comptable
| Capitalisation Boursière | Actions en Circulation | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices | Float |
|---|---|---|---|---|---|
| $ 232.77B | 5.56B | $ 11.15B | 1,90 | 21,90 | 5.55B |
| Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.44 | 3,44% | 05/09/2019 | -130.27k | 0,00% |
plus d’informations financières »
Actualités Action Pfizer
| Date | Heure | Source | Titre |
|---|---|---|---|
| 17/5/2019 | 21:50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 17/5/2019 | 21:50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 17/5/2019 | 21:50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 17/5/2019 | 21:50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 16/5/2019 | 19:21 | Dow Jones News | FDA Approves Pfizer's Fragmin for Use as a Pediatric.. |
| 15/5/2019 | 23:01 | Business Wire | Pfizer Oncology to Showcase New Data from Innovative Science.. |
| 15/5/2019 | 13:30 | Dow Jones News | Pfizer Sees Positive Top-Line Results in Abrocitinib Study |
Forum Action Pfizer
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Pfizer
| Période | Ouver. | Haut | Bas | VWAP | Vol. Mín | Vol. Max | Moyenne Vol. Quot. | Variation | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 semaine | 41,16 | 42,21 | 41,15 | 41,6345 | 23M | 28M | 25M | 0,7 | 1,70% |
| 1 mois | 39,25 | 42,21 | 39,165 | 40,9567 | 17M | 33M | 23M | 2,61 | 6,65% |
| 3 mois | 42,95 | 43,79 | 38,42 | 41,4582 | 12M | 71M | 24M | -1,09 | -2,54% |
| 6 mois | 42,95 | 46,47 | 38,1 | 42,0802 | 8M | 71M | 24M | -1,09 | -2,54% |
| 1 an | 35,68 | 46,47 | 35,32 | 41,5389 | 8M | 71M | 21M | 6,18 | 17,32% |
| 3 ans | 33,83 | 46,47 | 29,83 | 36,7789 | 6M | 113M | 20M | 8,03 | 23,74% |
| 5 ans | 29,57 | 46,47 | 27,51 | 34,4174 | 1k | 280M | 23M | 12,29 | 41,56% |
Pfizer Description
| Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments—Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare. |
